FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
03/18/2024
Back to search
Official data from USPTO
KRAS KONSTELLATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
03/18/2024
Trademark type
Combined
Nice classes
41, 42, 44
Filing date
09/06/2022
Registration date
11/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/21/2023
Last transaction
11/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DE
Examiner
LEHKER, DAWN FELDMAN
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized six-sided polygon in light blue with stylized bars over the polygon in shades of dark blue, light blue, purple, and pink forming a stylized letter K. The stylized dark blue wording "KRAS" appears next to the design, the stylized dark blue wording "KONSTELLATION" appears underneath the wording "KRAS".
Holders and representatives
Holders
Boehringer Ingelheim International GmbH
Representatives
Max Moskowitz OSTROLENK FABER LLP
Technical classification
Nice Classes
Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Organization and conducting of workshopsseminars and training courses for medical care and healthcare management in the field of oncological diseasesincluding online and via the internet
Class 42
Medical and scientific research in the fields of oncological diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Class 44
Medical services in the field of oncological diseasesincluding provided online via the internet
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/26/2024
FIMP
FINAL DISPOSITION PROCESSED
02/26/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/21/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2023
PUBO
PUBLISHED FOR OPPOSITION
09/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/16/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/16/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/31/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/31/2023
RFNT
REFUSAL PROCESSED BY IB
03/21/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/28/2023
RFRR
REFUSAL PROCESSED BY MPU
02/28/2023
DOCK
ASSIGNED TO EXAMINER
01/20/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/31/2022
CNRT
NON-FINAL ACTION WRITTEN
12/30/2022
DOCK
ASSIGNED TO EXAMINER
12/30/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/04/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/03/2022
Continuous trademark protection
Get notified about every new filing that threatens KRAS KONSTELLATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.